Patients should speak with a medical provider before using any GLP-1, GIP/GLP-1, or future triple-agonist medication
B.RidderstromM.MasimirembwaC
Evaluation of the effects of sodium-glucose co-transporter 2 inhibition with empagliflozin on morbidity and mortality in patients with chronic heart failure and a preserved ejection fraction: rationale for and design of the EMPEROR-Preserved Trial
What to Expect During Your JUVDERM Ultra XC Treatment Consultation: Your treatment begins with a consultation to discuss your goals and determine if JUVDERM Ultra XC is right for you
According to pioneers in Ipamorelin research, such as the team of Raun et al., the peptide apparently behaves as a growth hormone secretagogue (GHS) receptor agonist in pituitary cell cultures
Infliximab Infliximab, the mouse-human chimeric anti-TNF monoclonal antibody, was approved by the FDA for the treatment of PsA based on two pivotal trials known as the Infliximab Multinational Psoriatic Arthritis Controlled Trial (IMPACT) and IMPACT 2
